Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 16334-16335 [2014-06452]

Download as PDF 16334 Federal Register / Vol. 79, No. 57 / Tuesday, March 25, 2014 / Notices in, an entity is required to provide their Data Universal Numbering System (DUNS) number. FSRS then pulls core data about the entity from their System for Award Management (SAM) registration to include the legal business name, physical address, mailing address and Commercial and Government Entity (CAGE) code. The entity completes the FSRS registration by providing contact information within the entity for approval. If a prime awardee has already registered in FSRS to report contractsrelated Transparency Act financial data, a new log-in will not be required. In addition, if a prime awardee had a user account in the Electronic Subcontract Reporting System (eSRS), a new log-in will not be required. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC) Healthcare Infection Control Practices Advisory Committee (HICPAC) Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee: Respondents: 1,844. Responses Per Respondent: 1. Total annual responses: 1,844. Hours Per Response: .5. Total Burden Hours: 922. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW., Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 3090–0291, FSRS Registration Requirements for Prime Grant Awardees, in all correspondence. Times and Dates: 9:00 a.m.–5:00 p.m., April 10, 2014. 9:00 a.m.–12:00 p.m., April 11, 2014. Place: CDC Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/hicpac. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters for Discussion: The agenda will include updates on the Draft Guideline to Prevent Surgical Site Infections, CDC and Division of Healthcare Quality Promotion’s (DHQP’s) activities for prevention and surveillance of healthcare associated infections (HAI), core infection prevention and control practices and the Draft Health Care Personnel guideline. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333 Telephone (404) 639–4045. Email: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 18, 2014. Sonny Hashmi, Deputy Chief Information Officer, Office of the Deputy CIO. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–06555 Filed 3–24–14; 8:45 am] [FR Doc. 2014–06455 Filed 3–24–14; 8:45 am] BILLING CODE 6820–XY–P BILLING CODE 4163–18–P B. Public Comments Public comments are particularly invited on: Whether this collection of information is necessary for the proper performance of functions of the FSRS Registration Requirements for Prime Grant Awardees, whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected; and ways in which we can minimize the burden of the collection of information on those who are to respond, through the use of appropriate technological collection techniques or other forms of information technology. A 60-day notice, requesting comments was published in the Federal Register at 78 FR 79454 on December 30, 2013, no comments were received. C. Annual Reporting Burden emcdonald on DSK67QTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Mar<15>2010 18:16 Mar 24, 2014 Jkt 232001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned subcommittee: Time And Date: 11:00 a.m.–5:00 p.m., EST, April 16, 2014. Place: Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1–866–659–0537 and the pass code is 9933701. Status: Open to the public. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA tollfree, dial-in number, 1–866–659–0537 and the passcode is 9933701. Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the compensation program. Key functions of the ABRWH include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2015. Purpose: The ABRWH is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, providing advice to the Secretary on whether there is a class of employees at any Department of Energy facility who were E:\FR\FM\25MRN1.SGM 25MRN1 Federal Register / Vol. 79, No. 57 / Tuesday, March 25, 2014 / Notices emcdonald on DSK67QTVN1PROD with NOTICES exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is a reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee on Procedures Review was established to aid the ABRWH in carrying out its duty to advise the Secretary, HHS, on dose reconstructions. The Subcommittee on Procedures Review is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU). Matters For Discussion: The agenda for the Subcommittee meeting includes: discussion of procedures in the following ORAU and DCAS technical documents: ORAU Team Technical Information Bulletin (OTIB)0034 (‘‘Internal Dose Coworker Data for X–10’’), OTIB 0054 (‘‘Fission and Activation Product Assignment for Internal Dose-Related Gross Beta and Gross Gamma Analyses’’), OTIB 0083 (‘‘Dissolution Models for Insoluble Plutonium 238’’), Program Evaluation Report (PER) 011 (‘‘K–25 [Technical Basis Document] TBD and TIB Revisions’’), PER 020 (‘‘Blockson TBD Revision’’), PER 031 (‘‘Y–12 TBD Revisions’’), PER 033 (‘‘Reduction Pilot Plant TBD Revision’’), PER 038 (‘‘Hooker Electrochemical TBD Revisions’’); Update on Review of ORAU Team Report 0053 (‘‘Stratified Co-Worker Sets’’); discussion of estimating radiation doses associated with localized skin exposures to uranium at Atomic Weapons Employer facilities; and a continuation of the comment-resolution process for other dose reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate. Contact Person For More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E–20, Atlanta Georgia 30333, Telephone (513) 533–6800, Toll Free 1(800)CDC–INFO, Email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. 16335 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Research Approaches to Improve the Care and Outcomes of People Living with Spina Bifida, FOA DD14–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: The meeting announced below concerns A Creutzfeldt-Jakob Disease (CJD) Lookback Study: Assessing the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease, Funding Opportunity Announcement (FOA) CK14–005, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 9:00 a.m.–6:00 p.m., April 14, 2014 (Closed). 9:00 a.m.–6:00 p.m., April 15, 2014 (Closed). 9:00 a.m.–6:00 p.m., April 16, 2014 (Closed). 9:00 a.m.–6:00 p.m., April 17, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters For Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research Approaches to Improve the Care and Outcomes of People Living with Spina Bifida, FOA DD14–002, initial review.’’ Contact Person For More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Time And Date: 2:00 p.m.–3:30 p.m., EST, April 15, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters For Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘A Creutzfeldt-Jakob Disease (CJD) Lookback Study: Assessing the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease, FOA CK14–005, initial review.’’ Contact Person For More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–06451 Filed 3–24–14; 8:45 am] BILLING CODE 4163–18–P Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2014–06450 Filed 3–24–14; 8:45 am] Centers for Disease Control and Prevention BILLING CODE 4163–18–P [FR Doc. 2014–06452 Filed 3–24–14; 8:45 am] Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Initial Review BILLING CODE 4163–18–P The meeting announced below concerns Grants for Injury Control VerDate Mar<15>2010 18:16 Mar 24, 2014 Jkt 232001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\25MRN1.SGM 25MRN1

Agencies

[Federal Register Volume 79, Number 57 (Tuesday, March 25, 2014)]
[Notices]
[Pages 16334-16335]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06452]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Subcommittee on Procedures Review, Advisory Board on Radiation 
and Worker Health (ABRWH or Advisory Board), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
subcommittee:

    Time And Date: 11:00 a.m.-5:00 p.m., EST, April 16, 2014.
    Place: Audio Conference Call via FTS Conferencing. The USA toll-
free, dial-in number is 1-866-659-0537 and the pass code is 9933701.
    Status: Open to the public. The public is welcome to submit 
written comments in advance of the meeting, to the contact person 
below. Written comments received in advance of the meeting will be 
included in the official record of the meeting. The public is also 
welcome to listen to the meeting by joining the teleconference at 
the USA toll-free, dial-in number, 1-866-659-0537 and the passcode 
is 9933701.
    Background: The ABRWH was established under the Energy Employees 
Occupational Illness Compensation Program Act of 2000 to advise the 
President on a variety of policy and technical functions required to 
implement and effectively manage the compensation program. Key 
functions of the ABRWH include providing advice on the development 
of probability of causation guidelines that have been promulgated by 
the Department of Health and Human Services (HHS) as a final rule; 
advice on methods of dose reconstruction which have also been 
promulgated by HHS as a final rule; advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program; and advice 
on petitions to add classes of workers to the Special Exposure 
Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2015.
    Purpose: The ABRWH is charged with (a) providing advice to the 
Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, 
HHS, providing advice to the Secretary on whether there is a class 
of employees at any Department of Energy facility who were

[[Page 16335]]

exposed to radiation but for whom it is not feasible to estimate 
their radiation dose, and on whether there is a reasonable 
likelihood that such radiation doses may have endangered the health 
of members of this class. The Subcommittee on Procedures Review was 
established to aid the ABRWH in carrying out its duty to advise the 
Secretary, HHS, on dose reconstructions. The Subcommittee on 
Procedures Review is responsible for overseeing, tracking, and 
participating in the reviews of all procedures used in the dose 
reconstruction process by the NIOSH Division of Compensation 
Analysis and Support (DCAS) and its dose reconstruction contractor 
(Oak Ridge Associated Universities--ORAU).
    Matters For Discussion: The agenda for the Subcommittee meeting 
includes: discussion of procedures in the following ORAU and DCAS 
technical documents: ORAU Team Technical Information Bulletin 
(OTIB)0034 (``Internal Dose Coworker Data for X-10''), OTIB 0054 
(``Fission and Activation Product Assignment for Internal Dose-
Related Gross Beta and Gross Gamma Analyses''), OTIB 0083 
(``Dissolution Models for Insoluble Plutonium 238''), Program 
Evaluation Report (PER) 011 (``K-25 [Technical Basis Document] TBD 
and TIB Revisions''), PER 020 (``Blockson TBD Revision''), PER 031 
(``Y-12 TBD Revisions''), PER 033 (``Reduction Pilot Plant TBD 
Revision''), PER 038 (``Hooker Electrochemical TBD Revisions''); 
Update on Review of ORAU Team Report 0053 (``Stratified Co-Worker 
Sets''); discussion of estimating radiation doses associated with 
localized skin exposures to uranium at Atomic Weapons Employer 
facilities; and a continuation of the comment-resolution process for 
other dose reconstruction procedures under review by the 
Subcommittee.
    The agenda is subject to change as priorities dictate.
    Contact Person For More Information: Theodore Katz, Designated 
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20, 
Atlanta Georgia 30333, Telephone (513) 533-6800, Toll Free 
1(800)CDC-INFO, Email ocas@cdc.gov. The Director, Management 
Analysis and Services Office, has been delegated the authority to 
sign Federal Register notices pertaining to announcements of 
meetings and other committee management activities, for both the 
Centers for Disease Control and Prevention and the Agency for Toxic 
Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-06452 Filed 3-24-14; 8:45 am]
BILLING CODE 4163-18-P